We are live on ! Find out more
CKPT

Checkpoint Therapeutics

Delisted

CKPT was delisted on the 29th of May, 2025.

41 hedge funds and large institutions have $8.55M invested in Checkpoint Therapeutics in 2020 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 16 increasing their positions, 7 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 3

129% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 7

17% more funds holding

Funds holding: 3541 (+6)

0.05% less ownership

Funds ownership: 1.23%1.18% (-0.05%)

9% less capital invested

Capital invested by funds: $9.4M → $8.55M (-$849K)

Holders
41
Holders Change
+6
Holders Change %
+17.14%
% of All Funds
0.9%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
9
Increased
16
Reduced
7
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$2.61M +$374K +21,135 +14%
Vanguard Group
2
Vanguard Group
Pennsylvania
$2.3M +$74.8K +4,226 +3%
State Street
3
State Street
Massachusetts
$780K +$48.4K +2,735 +6%
Northern Trust
4
Northern Trust
Illinois
$644K +$259K +14,654 +52%
Geode Capital Management
5
Geode Capital Management
Massachusetts
$543K +$121K +6,846 +24%
Acadian Asset Management
6
Acadian Asset Management
Massachusetts
$182K +$60.5K +3,417 +40%
Bank of America
7
Bank of America
North Carolina
$153K -$3.59K -203 -2%
N
8
Nuveen
North Carolina
$142K +$54.1K +3,055 +48%
SAG
9
Spotlight Asset Group
Illinois
$121K
Charles Schwab
10
Charles Schwab
California
$114K +$48.2K +2,724 +57%
Royal Bank of Canada
11
Royal Bank of Canada
Ontario, Canada
$94K +$15.8K +891 +17%
Bank of New York Mellon
12
Bank of New York Mellon
New York
$83K +$18.8K +1,064 +24%
California State Teachers Retirement System (CalSTRS)
13
California State Teachers Retirement System (CalSTRS)
California
$81K +$31.9K +1,805 +51%
Renaissance Technologies
14
Renaissance Technologies
New York
$69K -$129K -7,280 -61%
Millennium Management
15
Millennium Management
New York
$67K -$71.2K -4,025 -48%
Wells Fargo
16
Wells Fargo
California
$57K -$1.34K -76 -2%
FAM
17
Fenimore Asset Management
New York
$49K
UBS Group
18
UBS Group
Switzerland
$48K +$2.42K +137 +5%
New York State Common Retirement Fund
19
New York State Common Retirement Fund
New York
$47K
Goldman Sachs
20
Goldman Sachs
New York
$35K +$40.5K +2,288 New
AIG
21
American International Group
New York
$31K +$9.79K +553 +36%
Susquehanna International Group
22
Susquehanna International Group
Pennsylvania
$30K +$35.3K +1,994 New
VOYA Investment Management
23
VOYA Investment Management
Georgia
$29K
RhumbLine Advisers
24
RhumbLine Advisers
Massachusetts
$26K
ECM
25
ExodusPoint Capital Management
New York
$21K +$24.2K +1,365 New

CKPT Hedge Fund Activity: Q1 2020 in Review

41 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Checkpoint Therapeutics (CKPT) for Q1 2020, worth a combined $8.55M — down 9% from $9.4M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new CKPT positions and 3 closed out — a net gain of 6 holders — while 16 added to existing stakes and 7 trimmed.

The largest buyer was BlackRock, adding an estimated $374K. The largest seller was Anson Funds Management, exiting entirely with an estimated $535K sold.

  • 41 institutional investors held Checkpoint Therapeutics (CKPT) as of Q1 2020, up from 35 in Q4 2019.
  • Funds reported $8.55M of Checkpoint Therapeutics stock for Q1 2020, down 9% quarter-over-quarter.
  • 9 funds opened new Checkpoint Therapeutics positions in Q1 2020 and 3 closed out, a net change of +6 holders.
  • The largest Checkpoint Therapeutics buyer in Q1 2020 was BlackRock, an estimated $374K added.
  • The largest Checkpoint Therapeutics seller in Q1 2020 was Anson Funds Management, an estimated $535K sold.

Based on aggregated 13F filings for Q1 2020.